Rarity Bioscience
PrivateLast Round
VC Round
Jun 18, 2024
Total Funding Raised
$3.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rarity Bioscience operates in Healthcare & Life Sciences and is based in Uppsala. Its latest recorded funding round was a VC Round in June 2024.
Rarity Bioscience is a biotechnology company that provides ultra-sensitive multiplex assays for mutation detection in liquid biopsies for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rarity Bioscience Comparables
Compare Rarity Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pillar Biosciences | 77% | |
| AccuraGen | 76% | |
| Sysmex Corporation | 76% |
For institutional investors. Book with your work email.
Rarity Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2024 | ||||
| Seed | Feb 6, 2023 | ||||
| Angel | Jul 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rarity Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navigare Ventures | Seed, VC Round |
| Uppsala University Invest | Angel, VC Round, Seed |
| Novalis Biotech | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 121% MoM, reaching 1.5K.
- Sep 9, 2025
Presented at the ADLM 2025 event, featuring CEO Linus Bosaeus.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 6, 2026
Rarity Bioscience AB further develops the superRCA method, which can detect a genetic mutation from a single malignant cell among 100,000 healthy cells and supports earlier acute myeloid leukemia relapse detection.
- recognized_asSep 30, 2026
Rarity Bioscience AB has been named the winner of the CYTO 2026 Innovation Technology Showcase, organized by the International Society for Advancement of Cytometry (ISAC), for its superRCA technology.
- launchesSep 17, 2026
Rarity Bioscience AB launches the superRCA Ultra-Sensitive KIT D816V Kit RUO in Sweden on Sep 17th '26 for ultra-sensitive, quantitative detection of the KIT D816V mutation.
For institutional investors. Book with your work email.
Rarity Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rarity Bioscience's valuation, stock price, and market status.
Is Rarity Bioscience a public or private company?
Rarity Bioscience is a private company.
What is the current stock price of Rarity Bioscience?
Rarity Bioscience is a private company, so its shares have no public market price. Caplight tracks Rarity Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rarity Bioscience worth (valuation)?
Valuation information for Rarity Bioscience is not publicly available.
Can I buy Rarity Bioscience stock?
Rarity Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rarity Bioscience's last funding round?
Rarity Bioscience's most recent funding round was VC Round on June 18, 2024.
Who are the main investors in Rarity Bioscience?
Key investors in Rarity Bioscience include Navigare Ventures, Uppsala University Invest.
Will Rarity Bioscience IPO soon?
No public IPO plans have been announced for Rarity Bioscience.
How can I track Rarity Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Rarity Bioscience's shares on secondary markets.